HealthEquity Retained Earnings (Accumulated Deficit) 2014-2024 | HQY
HealthEquity retained earnings (accumulated deficit) from 2014 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- HealthEquity retained earnings (accumulated deficit) for the quarter ending July 31, 2024 were $0.270B, a 64.2% increase year-over-year.
- HealthEquity retained earnings (accumulated deficit) for 2024 were $0.206B, a 37.16% increase from 2023.
- HealthEquity retained earnings (accumulated deficit) for 2023 were $0.15B, a 14.85% decline from 2022.
- HealthEquity retained earnings (accumulated deficit) for 2022 were $0.176B, a 20.1% decline from 2021.
| HealthEquity Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $206 |
| 2023 | $150 |
| 2022 | $176 |
| 2021 | $220 |
| 2020 | $212 |
| 2019 | $172 |
| 2018 | $85 |
| 2017 | $30 |
| 2016 | $4 |
| 2015 | $-13 |
| 2014 | $-23 |
| 2013 | $-19 |
| HealthEquity Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-07-31 | $270 |
| 2024-04-30 | $234 |
| 2024-01-31 | $206 |
| 2023-10-31 | $179 |
| 2023-07-31 | $165 |
| 2023-04-30 | $154 |
| 2023-01-31 | $150 |
| 2022-10-31 | $150 |
| 2022-07-31 | $152 |
| 2022-04-30 | $162 |
| 2022-01-31 | $176 |
| 2021-10-31 | $209 |
| 2021-07-31 | $214 |
| 2021-04-30 | $218 |
| 2021-01-31 | $220 |
| 2020-10-31 | $215 |
| 2020-07-31 | $213 |
| 2020-04-30 | $213 |
| 2020-01-31 | $212 |
| 2019-10-31 | $212 |
| 2019-07-31 | $233 |
| 2019-04-30 | $214 |
| 2019-01-31 | $172 |
| 2018-10-31 | $159 |
| 2018-07-31 | $143 |
| 2018-04-30 | $121 |
| 2018-01-31 | $85 |
| 2017-10-31 | $79 |
| 2017-07-31 | $69 |
| 2017-04-30 | $52 |
| 2017-01-31 | $30 |
| 2016-10-31 | $26 |
| 2016-07-31 | $20 |
| 2016-04-30 | $12 |
| 2016-01-31 | $4 |
| 2015-10-31 | $0 |
| 2015-07-31 | $-4 |
| 2015-04-30 | $-8 |
| 2015-01-31 | $-13 |
| 2014-10-31 | $-14 |
| 2014-07-31 | $-18 |
| 2014-04-30 | |
| 2014-01-31 | |
| 2013-10-31 | |
| 2013-07-31 | |
| 2013-01-31 | $-19 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.756B | $1.000B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $98.658B | 12.24 |
| Cencora (COR) | United States | $49.082B | 18.10 |
| DiDi Global (DIDIY) | China | $23.427B | 0.00 |
| ICON (ICLR) | Ireland | $17.504B | 15.59 |
| Natera (NTRA) | United States | $16.570B | 0.00 |
| Viatris (VTRS) | United States | $15.624B | 4.81 |
| Avantor (AVTR) | United States | $15.178B | 22.75 |
| Revvity (RVTY) | United States | $14.682B | 25.50 |
| BioMerieux (BMXMF) | France | $13.087B | 0.00 |
| CochLear (CHEOY) | Australia | $12.998B | 0.00 |
| Solventum (SOLV) | United States | $12.357B | 0.00 |
| Doximity (DOCS) | United States | $11.372B | 67.31 |
| Medpace Holdings (MEDP) | United States | $11.301B | 31.84 |
| Charles River Laboratories (CRL) | United States | $11.285B | 21.81 |
| Sonic Healthcare (SKHHY) | Australia | $8.590B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $7.202B | 33.53 |
| Life Times (LTH) | United States | $5.139B | 34.01 |
| Sotera Health (SHC) | United States | $4.509B | 24.12 |
| Organon (OGN) | United States | $4.144B | 4.18 |
| Surgery Partners (SGRY) | United States | $3.996B | 44.27 |
| BrightSpring Health Services (BTSG) | United States | $3.489B | 74.22 |
| PACS (PACS) | United States | $3.347B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.580B | 0.00 |
| Concentras Parent (CON) | United States | $2.505B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.471B | 0.00 |
| Premier (PINC) | United States | $2.314B | 11.55 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.016B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.856B | 48.90 |
| Teladoc Health (TDOC) | United States | $1.689B | 0.00 |
| Progyny (PGNY) | United States | $1.540B | 27.08 |
| Pediatrix Medical (MD) | United States | $1.371B | 13.41 |
| Establishment Labs Holdings (ESTA) | $1.266B | 0.00 | |
| CareDx (CDNA) | United States | $1.252B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.058B | 7.16 |
| Embecta (EMBC) | United States | $0.910B | 6.07 |
| Agilon Health (AGL) | United States | $0.890B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.809B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.723B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.516B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.459B | 0.00 |
| DocGo (DCGO) | United States | $0.411B | 15.46 |
| Enhabit (EHAB) | United States | $0.403B | 34.83 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| LifeMD (LFMD) | United States | $0.308B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.248B | 0.00 |
| ModivCare (MODV) | United States | $0.231B | 12.54 |
| Beauty Health (SKIN) | United States | $0.218B | 0.00 |
| Biodesix (BDSX) | United States | $0.205B | 0.00 |
| Nutex Health (NUTX) | United States | $0.152B | 0.00 |
| MultiPlan (MPLN) | United States | $0.137B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| So-Young (SY) | China | $0.088B | 21.28 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.054B | 0.00 |
| OncoCyte (OCX) | United States | $0.049B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.10 |
| Co-Diagnostics (CODX) | United States | $0.038B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |